Mukka Proteins Ltd Stock Price Today (NSE: MUKKA)
Fundamental Score
Mukka Proteins Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Mukka Proteins Ltd share price today is ₹23.45, up +0.00% on NSE/BSE as of 20 February 2026. Mukka Proteins Ltd (MUKKA) is a Small-cap company in the Animal Feed sector with a market capitalisation of ₹770.99 (Cr). The 52-week high for MUKKA share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 16.32x, MUKKA is currently trading below its industry average P/E of 18.96x. The company has a Return on Equity (ROE) of 11.10% and a debt-to-equity ratio of 1.37.
Mukka Proteins Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Mukka Proteins Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Mukka Proteins Share Price: A Financial Analysis for Growth and Dominance
The animal feed industry is currently experiencing a surge in demand driven by the global increase in aquaculture and livestock farming. This creates a fertile ground for companies strategically positioned within the sector. This analysis focuses on the financial health of Mukka Proteins Ltd, particularly its competitive standing based on the current Mukka Proteins share price of ₹24.639999, a PE ratio of 16.32, and a Return on Capital Employed (ROCE) of 11.59%. We will examine these figures in relation to its peers to assess its potential for growth and industry dominance.
Mukka Proteins' PE ratio of 16.32 suggests a valuation that is moderate compared to potential growth opportunities within the expanding animal feed market. However, a critical aspect affecting long-term value creation is management quality. While objectively assessing management is difficult from the outside, comparing publicly available information and strategic decisions can offer insight. For example, comparing Mukka Protein's expansion strategies with that of
Avanti Feeds Ltd could unveil key differences in management's risk appetite and capital allocation efficiency, ultimately affecting future performance.The ROCE of 11.59% is a crucial metric for understanding Mukka Proteins' profitability relative to its capital investments. This figure directly impacts the company's ability to build a sustainable economic moat. A higher ROCE indicates a stronger ability to generate profits, which can then be reinvested to further strengthen its competitive advantages, such as expanding production capacity, improving operational efficiency, or investing in research and development. However, this ROCE must be compared to industry averages and the cost of capital to determine if it is truly a competitive advantage.
This financial analysis of Mukka Proteins share price is an excerpt from a comprehensive 80-parameter fundamental audit. This audit, verified by Sweta Mishra, delves into various aspects of the company's financial standing, operational efficiency, and market position. The analysis is based on publicly available data and observational interpretations; no buy/sell recommendations are implied.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Mukka Proteins Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MUKKA across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (182.69%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (63.93%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (12.88% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (32.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (73.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Elevated Debt Levels (D/E: 1.37)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (2.43x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-376.69 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.36%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Mukka Proteins Ltd Financial Statements
Comprehensive financial data for Mukka Proteins Ltd including income statement, balance sheet and cash flow
About MUKKA (Mukka Proteins Ltd)
Mukka Proteins Ltd (MUKKA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Animal Feed sector with a current market capitalisation of ₹770.99 (Cr). Mukka Proteins Ltd has delivered a Return on Equity (ROE) of 11.10% and a ROCE of 11.59%. The debt-to-equity ratio stands at 1.37, reflecting the company's capital structure. Investors tracking MUKKA share price can monitor key metrics including P/E ratio, promoter holding of 73.33%, and quarterly earnings growth.
Company Details
Key Leadership
MUKKA Share Price: Frequently Asked Questions
What is the current share price of Mukka Proteins Ltd (MUKKA)?
As of 20 Feb 2026, 06:17 am IST, Mukka Proteins Ltd share price is ₹23.45. The MUKKA stock has a market capitalisation of ₹770.99 (Cr) on NSE/BSE.
Is MUKKA share price Overvalued or Undervalued?
MUKKA share price is currently trading at a P/E ratio of 16.32x, compared to the industry average of 18.96x. Based on this relative valuation, the Mukka Proteins Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of MUKKA share price?
The 52-week high of MUKKA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Mukka Proteins Ltd share price?
Key factors influencing MUKKA share price include quarterly earnings growth (Sales Growth: 63.93%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Mukka Proteins Ltd a good stock for long-term investment?
Mukka Proteins Ltd shows a 5-year Profit Growth of 32.54% and an ROE of 11.10%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.37 before investing in MUKKA shares.
How does Mukka Proteins Ltd compare with its industry peers?
Mukka Proteins Ltd competes with major peers in the Animal Feed. Investors should compare MUKKA share price P/E of 16.32x and ROE of 11.10% against the industry averages to determine competitive standing.
What is the P/E ratio of MUKKA and what does it mean?
MUKKA share price has a P/E ratio of 16.32x compared to the industry average of 18.96x. Investors pay ₹16 for every ₹1 of annual earnings.
How is MUKKA performing according to Bull Run's analysis?
MUKKA has a Bull Run fundamental score of 51.1/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MUKKA belong to?
MUKKA operates in the Animal Feed industry. This classification helps understand the competitive landscape and sector-specific trends affecting Mukka Proteins Ltd share price.
What is Return on Equity (ROE) and why is it important for MUKKA?
MUKKA has an ROE of 11.10%, which shows decent profitability but room for improvement. ROE measures how efficiently Mukka Proteins Ltd generates profits from shareholders capital.
How is MUKKA debt-to-equity ratio and what does it indicate?
MUKKA has a debt-to-equity ratio of 1.37, which indicates high leverage that increases financial risk.
What is MUKKA dividend yield and is it a good dividend stock?
MUKKA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Mukka Proteins Ltd shares.
How has MUKKA share price grown over the past 5 years?
MUKKA has achieved 5-year growth rates of: Sales Growth 12.88%, Profit Growth 32.54%, and EPS Growth N/A%.
What is the promoter holding in MUKKA and why does it matter?
Promoters hold 73.33% of MUKKA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Mukka Proteins Ltd.
What is MUKKA market capitalisation category?
MUKKA has a market capitalisation of ₹771 crores, placing it in the Small-cap category.
How volatile is MUKKA stock?
MUKKA has a beta of N/A. A beta > 1 suggests the Mukka Proteins Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MUKKA operating profit margin trend?
MUKKA has a 5-year average Operating Profit Margin (OPM) of 7.22%, indicating the company's operational efficiency.
How is MUKKA quarterly performance?
Recent quarterly performance shows Mukka Proteins Ltd YoY Sales Growth of 63.93% and YoY Profit Growth of 182.69%.
What is the institutional holding pattern in MUKKA?
MUKKA has FII holding of 1.70% and DII holding of 1.66%. Significant institutional holding often suggests professional confidence in the Mukka Proteins Ltd stock.